130 related articles for article (PubMed ID: 22907035)
1. Inhibition of HIV-1 protease expression in T cells owing to DNA aptamer-mediated specific delivery of siRNA.
Zhu Q; Shibata T; Kabashima T; Kai M
Eur J Med Chem; 2012 Oct; 56():396-9. PubMed ID: 22907035
[TBL] [Abstract][Full Text] [Related]
2. Receptor-targeted aptamer-siRNA conjugate-directed transcriptional regulation of HIV-1.
Zhou J; Lazar D; Li H; Xia X; Satheesan S; Charlins P; O'Mealy D; Akkina R; Saayman S; Weinberg MS; Rossi JJ; Morris KV
Theranostics; 2018; 8(6):1575-1590. PubMed ID: 29556342
[TBL] [Abstract][Full Text] [Related]
3. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
Wang XL; Wang QQ; Song HF
Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
[TBL] [Abstract][Full Text] [Related]
4. Smart ligand: aptamer-mediated targeted delivery of chemotherapeutic drugs and siRNA for cancer therapy.
Li X; Zhao Q; Qiu L
J Control Release; 2013 Oct; 171(2):152-62. PubMed ID: 23777885
[TBL] [Abstract][Full Text] [Related]
5. Aptamer-targeted RNAi for HIV-1 therapy.
Zhou J; Rossi JJ
Methods Mol Biol; 2011; 721():355-71. PubMed ID: 21431697
[TBL] [Abstract][Full Text] [Related]
6. An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice.
Neff CP; Zhou J; Remling L; Kuruvilla J; Zhang J; Li H; Smith DD; Swiderski P; Rossi JJ; Akkina R
Sci Transl Med; 2011 Jan; 3(66):66ra6. PubMed ID: 21248316
[TBL] [Abstract][Full Text] [Related]
7. Dual functional RNA nanoparticles containing phi29 motor pRNA and anti-gp120 aptamer for cell-type specific delivery and HIV-1 inhibition.
Zhou J; Shu Y; Guo P; Smith DD; Rossi JJ
Methods; 2011 Jun; 54(2):284-94. PubMed ID: 21256218
[TBL] [Abstract][Full Text] [Related]
8. Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels.
Hassani Z; Lemkine GF; Erbacher P; Palmier K; Alfama G; Giovannangeli C; Behr JP; Demeneix BA
J Gene Med; 2005 Feb; 7(2):198-207. PubMed ID: 15515135
[TBL] [Abstract][Full Text] [Related]
9. Development of cell-type specific anti-HIV gp120 aptamers for siRNA delivery.
Zhou J; Li H; Zhang J; Piotr S; Rossi J
J Vis Exp; 2011 Jun; (52):. PubMed ID: 21730942
[TBL] [Abstract][Full Text] [Related]
10. siRNA stabilization prolongs gene knockdown in primary T lymphocytes.
Mantei A; Rutz S; Janke M; Kirchhoff D; Jung U; Patzel V; Vogel U; Rudel T; Andreou I; Weber M; Scheffold A
Eur J Immunol; 2008 Sep; 38(9):2616-25. PubMed ID: 18792414
[TBL] [Abstract][Full Text] [Related]
11. Targeted siRNA delivery using aptamer-siRNA chimeras and aptamer-conjugated nanoparticles.
Sivakumar P; Kim S; Kang HC; Shim MS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1543. PubMed ID: 30070426
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Characterization of Aptamer-Targeted SNALPs for the Delivery of siRNA.
Wilner SE; Levy M
Methods Mol Biol; 2016; 1380():211-24. PubMed ID: 26552829
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of HIV transmission in human cervicovaginal explants and humanized mice using CD4 aptamer-siRNA chimeras.
Wheeler LA; Trifonova R; Vrbanac V; Basar E; McKernan S; Xu Z; Seung E; Deruaz M; Dudek T; Einarsson JI; Yang L; Allen TM; Luster AD; Tager AM; Dykxhoorn DM; Lieberman J
J Clin Invest; 2011 Jun; 121(6):2401-12. PubMed ID: 21576818
[TBL] [Abstract][Full Text] [Related]
14. siRNA-aptamer chimeras on nanoparticles: preserving targeting functionality for effective gene silencing.
Bagalkot V; Gao X
ACS Nano; 2011 Oct; 5(10):8131-9. PubMed ID: 21936502
[TBL] [Abstract][Full Text] [Related]
15. Stick-Based Methods for Aptamer-Mediated siRNA Targeted Delivery.
Catuogno S; Esposito CL; Giangrande PH
Methods Mol Biol; 2021; 2282():31-42. PubMed ID: 33928568
[TBL] [Abstract][Full Text] [Related]
16. Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.
Zhou J; Li H; Li S; Zaia J; Rossi JJ
Mol Ther; 2008 Aug; 16(8):1481-9. PubMed ID: 18461053
[TBL] [Abstract][Full Text] [Related]
17. Efficient and targeted delivery of siRNA in vivo.
Shim MS; Kwon YJ
FEBS J; 2010 Dec; 277(23):4814-27. PubMed ID: 21078116
[TBL] [Abstract][Full Text] [Related]
18. An aptamer-siRNA chimera silences the eukaryotic elongation factor 2 gene and induces apoptosis in cancers expressing αvβ3 integrin.
Hussain AF; Tur MK; Barth S
Nucleic Acid Ther; 2013 Jun; 23(3):203-12. PubMed ID: 23544955
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated delivery of siRNAs for anti-HIV therapy.
Kim SS; Subramanya S; Peer D; Shimaoka M; Shankar P
Methods Mol Biol; 2011; 721():339-53. PubMed ID: 21431696
[TBL] [Abstract][Full Text] [Related]
20. Targeted polymersome delivery of siRNA induces cell death of breast cancer cells dependent upon Orai3 protein expression.
Pangburn TO; Georgiou K; Bates FS; Kokkoli E
Langmuir; 2012 Sep; 28(35):12816-30. PubMed ID: 22827285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
